Evidence map›Paper›PMID 36817671›Full record

ArticleArchives of medical science : AMS2023

Is COVID-19 another case of the obesity paradox? Results from an international ecological study on behalf of the REPROGRAM Consortium Obesity study group.

Sonu Bhaskar, Sanja Jovanovic, Anubhav Katyal, Narayanan K Namboodiri, Dimitrios Chatzis, Maciej Banach

Open access · goldAbstract read
In one paragraph

Article in Archives of medical science : AMS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 5 countries.

Sonu BhaskarPandemic Health System REsilience PROGRAM (REPROGRAM) Global Consortium, Obesity REPROGRAM Study Group, Sydney, Australia.
Sanja JovanovicPandemic Health System REsilience PROGRAM (REPROGRAM) Global Consortium, Obesity REPROGRAM Study Group, Sydney, Australia.
Anubhav KatyalPandemic Health System REsilience PROGRAM (REPROGRAM) Global Consortium, Obesity REPROGRAM Study Group, Sydney, Australia.
Narayanan K NamboodiriPandemic Health System REsilience PROGRAM (REPROGRAM) Global Consortium, Obesity REPROGRAM Study Group, Sydney, Australia.
Dimitrios ChatzisPandemic Health System REsilience PROGRAM (REPROGRAM) Global Consortium, Obesity REPROGRAM Study Group, Sydney, Australia.
Maciej BanachPandemic Health System REsilience PROGRAM (REPROGRAM) Global Consortium, Obesity REPROGRAM Study Group, Sydney, Australia.
European University Cyprus · CYKwantlen Polytechnic University · CALiverpool Hospital · AUMedical University of Lodz · PLSree Chitra Thirunal Institute for Medical Sciences and Technology · INUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Obesity has emerged as one of the major risk factors of severe morbidity and cause-specific mortality among severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infected individuals. Patients with obesity also have overlapping cardiovascular diseases and diabetes, which make them increasingly vulnerable. This novel ecological study examines the impact of obesity and/or body mass index (BMI) on rates of population-adjusted cases and deaths due to coronavirus disease 2019 (COVID-19). Material and methods: Publicly available datasets were used to obtain relevant data on COVID-19, obesity and ecological variables. Group-wise comparisons and multivariate logistic regression analyses were performed. The receiver operating characteristic curve (ROC) was plotted to compute the area under the curve. Results: We found that male BMI is an independent predictor of cause-specific (COVID-19) mortality, and not of the caseload per million population. Countries with obesity rates of 20-30% had a significantly higher (approximately double) number of deaths per million population to both those in < 20% and > 30% slabs. We postulate that there may be a U-shaped paradoxical relationship between obesity and COVID-19 with the cause-specific mortality burden more pronounced in the countries with 20-30% obesity rates. These findings are novel along with the methodological approach of doing ecological analyses on country-wide data from publicly available sources. Conclusions: We anticipate, in light of our findings, that appropriate targeted public health approaches or campaigns could be developed to minimize the risk and cause-specific morbidity burden due to COVID-19 in countries with nationwide obesity rates of 20-30%.

Indexed as

coronavirus 2019 (COVID-19)demographicsmetabolic diseasenon-communicable diseases (NCDs)obesity

Identifiers

PMID36817671
PMCPMC9897093
OpenAlexW3162360359

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.